KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Emergent BioSolutions (EBS) Return on Assets (2016 - 2025)

Historic Return on Assets for Emergent BioSolutions (EBS) over the last 17 years, with Q3 2025 value amounting to 0.05%.

  • Emergent BioSolutions' Return on Assets rose 1900.0% to 0.05% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.05%, marking a year-over-year increase of 1900.0%. This contributed to the annual value of 0.12% for FY2024, which is 1900.0% up from last year.
  • As of Q3 2025, Emergent BioSolutions' Return on Assets stood at 0.05%, which was up 1900.0% from 0.1% recorded in Q2 2025.
  • In the past 5 years, Emergent BioSolutions' Return on Assets ranged from a high of 0.13% in Q1 2021 and a low of 0.41% during Q4 2023
  • Its 5-year average for Return on Assets is 0.09%, with a median of 0.07% in 2022.
  • Its Return on Assets has fluctuated over the past 5 years, first tumbled by -3900bps in 2023, then skyrocketed by 4500bps in 2025.
  • Emergent BioSolutions' Return on Assets (Quarter) stood at 0.08% in 2021, then tumbled by -194bps to 0.07% in 2022, then tumbled by -479bps to 0.41% in 2023, then skyrocketed by 68bps to 0.13% in 2024, then soared by 140bps to 0.05% in 2025.
  • Its last three reported values are 0.05% in Q3 2025, 0.1% for Q2 2025, and 0.09% during Q1 2025.